JPS5949238B2 - How to separate protamine - Google Patents
How to separate protamineInfo
- Publication number
- JPS5949238B2 JPS5949238B2 JP53073743A JP7374378A JPS5949238B2 JP S5949238 B2 JPS5949238 B2 JP S5949238B2 JP 53073743 A JP53073743 A JP 53073743A JP 7374378 A JP7374378 A JP 7374378A JP S5949238 B2 JPS5949238 B2 JP S5949238B2
- Authority
- JP
- Japan
- Prior art keywords
- protamine
- acid
- salt
- sulfate
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000007327 Protamines Human genes 0.000 title claims description 54
- 108010007568 Protamines Proteins 0.000 title claims description 54
- 229940048914 protamine Drugs 0.000 title claims description 46
- 150000003839 salts Chemical class 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 241000251468 Actinopterygii Species 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 229950008679 protamine sulfate Drugs 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 125000005341 metaphosphate group Chemical group 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- ZVUUCUFDAHKLKT-UHFFFAOYSA-M sodium;2,4,6-trinitrophenolate Chemical compound [Na+].[O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O ZVUUCUFDAHKLKT-UHFFFAOYSA-M 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000016261 Long-Acting Insulin Human genes 0.000 description 1
- 108010092217 Long-Acting Insulin Proteins 0.000 description 1
- 229940100066 Long-acting insulin Drugs 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- VRWKTAYJTKRVCU-UHFFFAOYSA-N iron(6+);hexacyanide Chemical compound [Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] VRWKTAYJTKRVCU-UHFFFAOYSA-N 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- CMPGARWFYBADJI-UHFFFAOYSA-L tungstic acid Chemical compound O[W](O)(=O)=O CMPGARWFYBADJI-UHFFFAOYSA-L 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】
本発明は、プロタミンを含む白子より得たプロタミン抽
出液より、簡易にプロタミン鉱酸塩を分離する方法に関
するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for easily separating protamine mineral salts from a protamine extract obtained from milt containing protamine.
プロタミンはサケ、マス、ニシン、サバ等の精子核中に
デオキシリボ核酸と結合したヌクレオブロタミンとして
存在する比較的分子量の小さい高アルギニン含量の強塩
基性タンパク質である。Protamine is a strong basic protein with a relatively small molecular weight and high arginine content, which exists as nucleobrotamine bound to deoxyribonucleic acid in the sperm nuclei of salmon, trout, herring, mackerel, etc.
プロタミンは古くより、インシュリンとの複合体である
効力持続性インシュリン製剤や抗へバリン剤であるプロ
タミン注射液が臨床薬剤として使用されていると同時に
、生化学研究および生化学工業において分離、精製用薬
剤としても利用されているが、近時、ある種の酵素の安
定剤や抗性物質等の活性剤あるいは助剤としても不可欠
の物質となりつゝある。従来、プロタミンの製造法とし
ては、前記魚の成熟白子を肉挽機で磨砕し、4〜5倍容
の水に懸濁させ十分撹拌した後、布または金網でろ過し
た乳状液を攪拌下に希酢酸でリトマス酸性にして凝集す
る精子核を遠心分離する。Protamine has long been used as a clinical drug in the form of long-acting insulin preparations, which are complexes with insulin, and protamine injections, which are antihebarin drugs. Although it is also used as a medicine, it has recently become an indispensable substance as a stabilizer for certain enzymes and as an activator or auxiliary agent for anti-inflammatory substances. Conventionally, protamine has been produced by grinding the mature milt of the fish in a meat grinder, suspending it in 4 to 5 times the volume of water, stirring thoroughly, and then filtering the emulsion through a cloth or wire mesh while stirring. Litmus acidify with dilute acetic acid and centrifuge the aggregated sperm nuclei.
さらに酢酸々性の水で洗浄を繰返し、必要に応じてアル
コールで脱脂、乾燥する。つぎにこの精子核を希鉱酸で
一定時覚抽出して、残渣を遠心分離して除去し、なお残
渣の抽出を繰返す。Furthermore, it is repeatedly washed with acetic acid water, and if necessary, it is degreased with alcohol and dried. Next, this sperm nucleus is extracted with dilute mineral acid for a certain period of time, the residue is removed by centrifugation, and the extraction of the residue is repeated.
ついで抽出液に2〜3倍容のアルコールを加えてプロタ
ミン硫酸塩として分離するか、またはピクリン酸ナトリ
ウムでプロタミン・ピクリン酸塩として沈澱させ、さら
に硫酸とアルコールでプロタミン硫酸塩として分離する
か、あるいはまた、他の一般のタンパク沈澱剤(塩化白
金、タングステン酸、メタ燐酸、フェロシアン化水素酸
、スルホサルチル酸等)で分離し、常法により硫酸塩と
するのが一般的である。プロタミンの精製法として最も
一般的なものは、硫酸塩としてアルコールによる再沈澱
の反覆であるが、近時一般的となつたイオン交換樹脂に
よる分離精製法も行なわれている。Then, add 2 to 3 times the volume of alcohol to the extract to separate it as protamine sulfate, or precipitate it as protamine picrate with sodium picrate, and then separate it as protamine sulfate with sulfuric acid and alcohol, or In addition, it is common to separate with other general protein precipitants (platinum chloride, tungstic acid, metaphosphoric acid, ferrocyanic acid, sulfosalcylic acid, etc.) and convert it into a sulfate by a conventional method. The most common method for purifying protamine is to repeat the reprecipitation with alcohol as a sulfate, but separation and purification using ion exchange resins, which have recently become commonplace, is also carried out.
いずれにしても、これら従来のプロタミンの製造法は、
総じて操作が煩雑で多大の労力を要するか、または高価
な機械装置あるいは資材を必要とするかして、大量生産
には不適当であるのみか、品質の純度と収率の相反も重
なつて経済的にも著しく不利である。In any case, these conventional protamine production methods are
In general, operations are complicated and require a lot of labor, or expensive machinery and materials are required, making them unsuitable for mass production, and there is also a conflict between quality purity and yield. It is also extremely disadvantageous economically.
本発明は、これら従来のプロタミンの製造法中、プロタ
ミン抽出液からプロタミンを分離する方法につき、その
操作の煩雑さ、経済的な不利、収率の悪さを解消するも
のである。The present invention solves the complicated operations, economical disadvantages, and poor yields of the method for separating protamine from a protamine extract among these conventional protamine production methods.
本発明の特徴は、プロタミンを含む魚の白子より得たプ
ロタミン抽出液に、縮合燐酸あるいはその塩を加えて難
溶性のプロタミン塩として沈澱させ、これを高濃度無機
塩類で複分解することによりプロタミン鉱酸塩を分離す
る方法にある。The feature of the present invention is that condensed phosphoric acid or its salt is added to a protamine extract obtained from fish milt containing protamine to precipitate a sparingly soluble protamine salt, and this is double decomposed with a high concentration inorganic salt to produce protamine mineral acid. In the method of separating salt.
以下本発明による方法を詳細に説明する。従来法のよう
にプロタミン抽出液に大量(約3倍容)のアルコールを
添加してプロタミン鉱酸塩を沈澱、分離する方法は、た
K単に経済的な不利ばかりでなく、プロタミン以外の不
純物も共沈させることkなり、精製操作が煩雑となる欠
点も伴う。The method according to the present invention will be explained in detail below. The conventional method of adding a large amount (approximately 3 times the volume) of alcohol to the protamine extract to precipitate and separate protamine mineral salts is not only economically disadvantageous, but also contains impurities other than protamine. Co-precipitation is required, which also has the disadvantage of complicating purification operations.
またピクリン酸ナトリウムにより沈澱させた場合は、6
7%アセトン水溶液中で希塩酸とエーテルでピクリン酸
を除去し、硫酸とアルコールでプロタミン硫酸塩として
分離するのであるが、特,有の黄色を呈するピクリン酸
の痕跡を完全に除去することが至難であつて、著しい収
率の低下を招く。他の一般タンパク沈澱剤を使用した場
合も、おおむね同様の欠点を有する。本発明においては
、極めて一般にありふれた食2品添加物としても日常大
量に使用されている縮合燐酸またはその塩を活用して、
難溶性のプロタミン塩で分離すると同時に、一部精製効
果も利用するものである。In addition, when precipitated with sodium picrate, 6
Picric acid is removed with dilute hydrochloric acid and ether in a 7% acetone aqueous solution, and then separated as protamine sulfate with sulfuric acid and alcohol, but it is extremely difficult to completely remove traces of picric acid, which has a characteristic yellow color. In some cases, this results in a significant decrease in yield. The use of other general protein precipitants has generally similar drawbacks. In the present invention, we utilize condensed phosphoric acid or its salt, which is used in large quantities daily as an extremely common food additive.
In addition to separating using a sparingly soluble protamine salt, it also makes use of some purification effects.
縮合燐殿およびその塩は、一般にタンパク質の2沈澱剤
として知られているものであり、プロタミンの分離精製
に使用された例が米国特許第2497858にある。Condensed phosphorus precipitates and their salts are generally known as protein precipitants, and an example of their use in the separation and purification of protamine is found in US Pat. No. 2,497,858.
しかしながら、この方法が広く一般化しなかつた理由は
、プロタミンの縮合燐酸塩を通常の鉱酸塩に換える方法
に欠陥があ3つたからである。因に米国特許第2497
854においては、プロタミンメタ燐酸塩を1N硫酸に
加゛熱溶解して完全に硫酸塩に変じてしまうまで煮沸し
た後に、アルコールまたはアセトンを加えてプロタミン
硫酸塩を得るという操作に依つているこ 3.とである
。当然のことながらタンパク質の加水分解の条件が滲う
結果、得られるプロタミンは何らかの損傷を受けるおそ
れがあり、これがために採用をためられれたものである
。本発明の方法は、プロタミン縮合燐酸塩を高濃φ度無
機塩類で複分解することにより、容易にプロタミン鉱酸
塩が得られるという新知見に基いて採用されたものであ
る。However, the reason why this method has not become widely popular is that there were three flaws in the method of replacing the condensed phosphate of protamine with a common mineral salt. Incidentally, U.S. Patent No. 2497
854 relies on the procedure of heating and dissolving protamine metaphosphate in 1N sulfuric acid, boiling it until it is completely converted to sulfate, and then adding alcohol or acetone to obtain protamine sulfate. .. That is. Naturally, as a result of the conditions for protein hydrolysis, the resulting protamine may be damaged in some way, and for this reason, its use was discouraged. The method of the present invention was adopted based on the new finding that protamine mineral salts can be easily obtained by double decomposing protamine condensed phosphates with high-concentration φ-concentration inorganic salts.
プロタミン縮合燐酸塩は、1N硫酸ですら加熱煮沸して
始めて溶解するにもかXわらず、高濃度無機塩類には容
易に溶解して、プロタミンと縮合燐酸にほK完全に解離
した状態にあり、適当な塩濃度と温度変化という単純な
操作のみでプロタミン鉱酸塩を油状に分離し、分液操作
のみで単離することができる。縮合燐酸およびその塩は
、メタ燐酸、ポリ燐酸およびそれらの塩類いずれでも使
用できる。Although protamine condensed phosphate dissolves only in 1N sulfuric acid by heating and boiling, it easily dissolves in high concentration inorganic salts, and is completely dissociated into protamine and condensed phosphoric acid. Protamine mineral salts can be separated into an oily state by simple operations such as appropriate salt concentration and temperature changes, and can be isolated using only liquid separation operations. As the condensed phosphoric acid and its salts, any of metaphosphoric acid, polyphosphoric acid, and salts thereof can be used.
また複分解用の無機塩類も鉱酸のアルカリ塩、アルカリ
土類塩またはアンモニウム塩等いずれも目的に応じて選
択することができる。プロタミン縮合燐酸塩の溶解性は
、無機塩濃度がほK2モルの場合が最大であるが、0.
5モルより飽和溶液に近い濃度まで液量および温度との
関連に応じて自由に選択できる。また、溶解温度も塩濃
度および液量に応じて適宜・【採用され、要は温度差に
よりプロタミンが油状に得られる条件を選べばよい。硫
酸塩を使用すればプロタミン硫酸塩が油状に分離し、ア
ルコールまたはアセトンにより脱水固化すれば硫酸プロ
タミンの白色粉末が得られる。本発明に使用されるプロ
タミンの抽出液は、前述したような従来法によつても得
ることができるが、好ましくは本発明者らによつて見い
出された次の方法によるのがよい、すなわち、プロタミ
ンを含有する魚の白子を磨砕することなく、そのまXの
形状で直接希鉱酸を作用させて抽出する方法である。Further, inorganic salts for metathesis such as alkali salts, alkaline earth salts or ammonium salts of mineral acids can be selected depending on the purpose. The solubility of protamine condensed phosphate is maximum when the inorganic salt concentration is about 2 moles, but 0.
The concentration can be freely selected from 5 mol to a concentration closer to a saturated solution depending on the relationship with the liquid volume and temperature. In addition, the dissolution temperature can be adjusted as appropriate depending on the salt concentration and liquid volume, and the key is to select conditions that allow protamine to be obtained in the form of an oil based on the temperature difference. If a sulfate is used, protamine sulfate will separate into an oily state, and if it is dehydrated and solidified with alcohol or acetone, a white powder of protamine sulfate will be obtained. Although the protamine extract used in the present invention can be obtained by the conventional method as described above, it is preferably obtained by the following method discovered by the present inventors. This is a method for extracting protamine-containing fish milt by directly exposing it to dilute mineral acid in the form of X without grinding it.
また、本発明により分離されたプロタミンは、前述した
ような従来法によつて、さらに精製することができる。Furthermore, the protamine separated according to the present invention can be further purified by conventional methods such as those described above.
工業的に大量生産するのに適した方法としては、本発明
者らによつて見い出された次の方法によるのが好ましい
。すなわち、プロタミン抽出液より分離して得たプロタ
ミン鉱酸塩の酸性希薄水溶液を吸着剤で処理した後に、
必要最少限量またはそれ以下の有機溶剤で分別沈澱させ
る方法である。以下、実施例および参考例をあげる。As a method suitable for industrial mass production, the following method discovered by the present inventors is preferred. That is, after treating an acidic dilute aqueous solution of protamine mineral salt obtained by separating it from a protamine extract with an adsorbent,
This is a method of fractional precipitation using the minimum amount of organic solvent required or less. Examples and reference examples are given below.
参考例
11月下旬に岩手県宮古で魚獲されたサケの凍結白子1
0.0kgを一夜放置して解凍し、0.5N塩酸250
1を加え、常温で液の循環下に5時間抽出して、プロタ
ミン抽出液を得る。Reference example: Frozen salmon milt 1 caught in Miyako, Iwate Prefecture in late November
Leave 0.0kg overnight to thaw, add 0.5N hydrochloric acid 250
1 and extracted for 5 hours at room temperature while circulating the liquid to obtain a protamine extract.
実施例
上記参考例により得たプロタミン抽出液をアンモニア水
でPFI3〜4に調整し、これに2.3kgのメ夕燐酸
ナトリウムの水溶液を攪拌しつX添加して一夜放置する
。EXAMPLE The protamine extract obtained in the above reference example was adjusted to a PFI of 3 to 4 with aqueous ammonia, and 2.3 kg of an aqueous solution of sodium metaphosphate was added thereto with stirring and left overnight.
上澄を傾瀉してアメ状のプロタミンメタ燐酸塩7.51
<gを1.51の硫酸アンモニウムに加温溶解して一夜
放置する。下層の抽状プロタミン硫酸塩を分液し、アル
コールで脱水、固化、乾燥して4。5kgの硫酸プロタ
ミンの白色粉末を得る。Decant the supernatant to obtain candy-like protamine metaphosphate 7.51
<g is dissolved in 1.51 ammonium sulfate with heating and left overnight. The extracted protamine sulfate in the lower layer is separated, dehydrated with alcohol, solidified, and dried to obtain 4.5 kg of white powder of protamine sulfate.
Claims (1)
液に、縮合燐酸またはその塩を加えて難溶性のプロタミ
ン塩として沈澱させ、これを高濃度無機塩類で複分解し
てプロタミン鉱酸塩とすることを特徴とするプロタミン
の分離方法。1. Condensed phosphoric acid or its salt is added to a protamine extract obtained from fish milt containing protamine to precipitate a sparingly soluble protamine salt, which is double decomposed with high concentration inorganic salts to produce a protamine mineral salt. A method for separating protamine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53073743A JPS5949238B2 (en) | 1978-06-20 | 1978-06-20 | How to separate protamine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53073743A JPS5949238B2 (en) | 1978-06-20 | 1978-06-20 | How to separate protamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS552603A JPS552603A (en) | 1980-01-10 |
| JPS5949238B2 true JPS5949238B2 (en) | 1984-12-01 |
Family
ID=13527018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53073743A Expired JPS5949238B2 (en) | 1978-06-20 | 1978-06-20 | How to separate protamine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5949238B2 (en) |
-
1978
- 1978-06-20 JP JP53073743A patent/JPS5949238B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS552603A (en) | 1980-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4661606A (en) | Extraction of amino acids from aqueous mixtures and quaternary ammonium salt intermediates produced therein | |
| US3988344A (en) | Process for purifying saccharin | |
| JPS5949238B2 (en) | How to separate protamine | |
| Jacobs et al. | CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS: CHEMICAL SERIES. I. N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID | |
| US4886888A (en) | Extraction of amino an acid from aqueous mixtures thereof | |
| US5349074A (en) | Process for pharmaceutical grade high purity hyodeoxycholic acid preparation | |
| JPS5931519B2 (en) | Extraction, separation and purification method of high purity protamine | |
| US3875138A (en) | Process for recovering glucagon | |
| NL8002273A (en) | METHOD FOR EXTRACTING SPECTOMYCIN FROM AN AQUEOUS CONCENTRATE | |
| Frankel et al. | Synthesis of α-amino-γ-halogenobutyric acids. A new synthesis of dl-homoserine | |
| US4150117A (en) | Process for the preparation of gastrointestinal hormone | |
| JPS5829294B2 (en) | Method for purifying isoleucine from a mixture of leucine and isoleucine | |
| Daubney et al. | An investigation into the methods of toxicological analysis of viscera | |
| JPS5931518B2 (en) | How to extract protamine | |
| NISHIMOTO et al. | Phosphatides of the Human Brain IV. The Separation of α-and β-Kephalins | |
| Clarke | LV.—Phytin and phytic acid | |
| JPH05500205A (en) | Hemin purification method, new hemin derivatives and their production method | |
| JPS5949239B2 (en) | Simple purification method for high-purity protamine | |
| KR810000931B1 (en) | How to Extract Aristolokine | |
| US2331574A (en) | Process of recovering bilirubin | |
| KR880001120B1 (en) | Process for purifying elastase | |
| US2879203A (en) | Recovery of vitamin b12 from diluted solutions | |
| US4237295A (en) | Process for the production of 17-hydroxysparteine by oxidation of sparteine with a permanganate | |
| RU2611409C1 (en) | Method for producing copper complex of chlorophyll | |
| CA1043775A (en) | Process for recovering glucagon |